Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Sarcoma, Kaposi × pembrolizumab × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Melanoma 8 Squamous Cell Carcinoma of Head and Neck 6 Head and Neck Neoplasms 6 Carcinoma, Transitional Cell 6 Breast Neoplasms 6 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 5 Neoplasms 5 Multiple Myeloma 5 Carcinoma, Renal Cell 5 Recurrence 3 Lung Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Kidney Neoplasms 2 Hematologic Neoplasms 2 Glioblastoma 2 Brain Neoplasms 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Spinocerebellar Degenerations 1 Sezary Syndrome 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma 1 Rectal Neoplasms 1

Interventions

pembrolizumab 1 nirogacestat 1 lenvatinib 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05846724 2026-01-22

PULSAR

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Phase 2 Withdrawn

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡